NeurAxis Overview

  • Status
  • Public

  • Employees
  • 22

Employees

  • Stock Symbol
  • NRXS

Stock Symbol

  • Share Price
  • $2.54
  • (As of Friday Closing)

NeurAxis General Information

Description

Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 829 South Adams Street
  • Versailles, IN 47042
  • United States
+1 (812)
Primary Industry
Therapeutic Devices
Stock Exchange
ASE
Vertical(s)
Corporate Office
  • 829 South Adams Street
  • Versailles, IN 47042
  • United States
+1 (812)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NeurAxis Stock Performance

As of 07-Feb-2025, NeurAxis’s stock price is $2.54. Its current market cap is $18.3M with 7.18M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.54 $2.50 $2.05 - $3.89 $18.3M 7.18M 28.1K -$0.40

NeurAxis Financials Summary

As of 30-Sep-2024, NeurAxis has a trailing 12-month revenue of $2.46M.

In Thousands,
USD
TTM 30-Sep-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 25,036 13,641
Revenue 2,456 2,460 2,685 2,721
EBITDA (8,022) (9,228) (4,325) (2,954)
Net Income (8,386) (14,627) (4,780) (3,028)
Total Assets 1,143 509 1,481 760
Total Debt 477 224 599 439
Public Fundamental Data provided by Morningstar, Inc. disclaimer

NeurAxis Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore NeurAxis‘s full profile, request access.

Request a free trial

NeurAxis Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore NeurAxis‘s full profile, request access.

Request a free trial

NeurAxis Patents

NeurAxis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220387817-A1 Device and method for eradicating pathogens in nasal passages Pending 07-Jun-2021
US-20220370673-A1 Disinfection chambers and tunnels Pending 15-Jun-2020
US-20220347474-A1 External auditory canal therapy device Pending 26-Jun-2019
US-20220176151-A1 External auditory canal photobiomodulation and audio therapy device Pending 26-Jun-2019
CA-3143304-A1 External auditory canal photobiomodulation device Pending 26-Jun-2019 A61N5/0603
To view NeurAxis’s complete patent history, request access »

NeurAxis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NeurAxis Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore NeurAxis‘s full profile, request access.

Request a free trial

NeurAxis FAQs

  • Where is NeurAxis headquartered?

    NeurAxis is headquartered in Versailles, IN.

  • What is the size of NeurAxis?

    NeurAxis has 22 total employees.

  • What industry is NeurAxis in?

    NeurAxis’s primary industry is Therapeutic Devices.

  • Is NeurAxis a private or public company?

    NeurAxis is a Public company.

  • What is NeurAxis’s stock symbol?

    The ticker symbol for NeurAxis is NRXS.

  • What is the current stock price of NeurAxis?

    As of 07-Feb-2025 the stock price of NeurAxis is $2.54.

  • What is the current market cap of NeurAxis?

    The current market capitalization of NeurAxis is $18.3M.

  • What is NeurAxis’s current revenue?

    The trailing twelve month revenue for NeurAxis is $2.46M.

  • What is NeurAxis’s annual earnings per share (EPS)?

    NeurAxis’s EPS for 12 months was -$0.40.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »